Corporate Negative

Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting

Breaking news from global financial markets

il y a 1 semaine
Lire Plus